Warenkorb -  AGBs -  Datenschutz -  Contact us   

Imaging in Clinical Oncology


GOULIAMOS / ANDREOU / KOSMIDIS  

Imaging in Clinical Oncology

709 Seiten, 2. Auflage, 2018
245 Abbildungen

  • Discusses and illustrates the presentation of a broad spectrum of oncologic diseases in currently available imaging modalities
  • Recommends key principles of radiologic-oncologic interrelation and applies these principles in the interpretation of radiologic studies
  • Considers the role of multiparametric and multimodality imaging approaches in detail
This is the second edition of a well-received book reflecting the state of the art in oncologic imaging research and promoting mutual understanding and collaboration between radiologists and clinical oncologists. It presents all currently available imaging modalities and covers a broad spectrum of oncologic diseases for most organ systems.

Today, oncologic imaging faces the challenge of improving and refining concepts for precise tumor delineation and biologic/functional tumor characterization, as well as for purposes of creating individual treatment plans. The concept of radiomics has further advanced the conversion of images into mineable data and subsequent analysis of said data for decision-making support.

Since the release of the book’s first edition, radiomics has been introduced in oncology studies and can be performed with tomographic images from CT, MRI and PET/CT studies. The combination of radiomic data with genomic features is known as radiogenomics, and can potentially offer additional decision-making support.

This book will be of interest to clinical oncologists with regard to the diagnosis, staging, treatment and follow-up on various tumors affecting the CNS, chest, abdomen, urogenital and musculoskeletal systems.

Table of Contents
  • Part I Introductory.-
  • Part II Bone and soft Tissue Tumors.-
  • Part III CNS Tumors.-
  • Part IV Head and Neck Cancer.-
  • Part V Lung Cancer.-
  • Part VI Breast Cancer.-
  • Part VII Gynecologic Cancer.-
  • Part VIII Gastrointestinal Cancer.-
  • Part IX Neuroendocrine Tumors.-
  • Part X Urogenital Cancer.-
  • Part XI Lymphomas.-
  • Part XII Multiple Myeloma.-
  • Part XIII Melanoma.

€ 228,98
   
versandkostenfrei - in acht bis zehn Werktagen lieferbar Anzahl:
Preis: € 228,98